Chuan-Ming Xie

third military medical university (army medical university)

H指数:23

被引数:1,746

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis

靶向RPL4可提高PD-L1阻断在肝纤维化中的治疗效果

Cell Reports Medicine

IF10.6

2026-09-220

OAAI

FBXO6 ubiquitinates MAOA to promote monoamine neurotransmitter accumulation and tumor growth in HCC

FBXO6泛素化MAOA以促进单胺神经递质积累和肝癌肿瘤生长

Journal of Molecular Cell Biology

IF5.9

2026-08-170

OAAI

Elevated FBXO45 promotes TFG ubiquitination and drives lung metastasis of hepatocellular carcinoma

FBXO45的上调促进TFG泛素化并驱动肝细胞癌的肺转移

JHEP Reports

IF7.5

2025-07-090

OAAI

Ganoderic acid T, a novel activator of pyruvate carboxylase, exhibits potent anti-liver cancer activity

Ganoderic acid T，一种新型的丙酮酸羧化酶激活剂，表现出强大的抗肝癌活性。

Metabolism

IF0

2025-06-040

PRE

Macrophage miR-4524a-5p/TBP promotes β-TrCP-TIM3 complex activation and TGFβ release and aggravates NAFLD-associated fibrosis

巨噬细胞miR-4524a-5p/TBP促进β-TrCP-TIM3复合物激活和TGFβ释放，并加重NAFLD相关纤维化

CELL DEATH & DISEASE

IF9.6

2025-04-190

RETRACTION: [Retracted] Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib

ONCOLOGY REPORTS

IF3.9

2025-01-130

PRE

Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2024-01-044

OAAI

Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice

MILITARY MEDICAL RESEARCH

IF22.9

2023-12-209

OAAI

S ilencing of FAM111B inhibited proliferation, migration and invasion of hepatoma cells through activating p53 pathway

DIGESTIVE AND LIVER DISEASE

IF3.8

2023-12-013

PRE

Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice (vol 55, pg 2162, 2023)

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2023-10-020

OAAI

Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2023-09-016

OAAI

Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice

CELL REPORTS

IF6.9

2023-07-018

FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males

CANCER LETTERS

IF10.1

2023-07-017

PRE

Elevated FBXL18 promotes RPS15A ubiquitination and SMAD3 activation to drive HCC

HEPATOLOGY COMMUNICATIONS

IF4.6

2023-07-012

OAAI

FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration

FBXO43增强CCND1稳定性促进肝癌细胞增殖和迁移

FRONTIERS IN ONCOLOGY

IF3.3

2023-03-0310

OAAI

Cancer type classification using plasma cell-free RNAs derived from human and microbes

ELIFE

IF0

2022-07-1133

Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling

THERANOSTICS

IF13.3

2022-01-0110

OAAI

Elevated Sodium Pump α3 Subunit Expression Promotes Colorectal Liver Metastasis via the p53-PTEN/IGFBP3-AKT-mTOR Axis

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-124

OAAI

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma

JOURNAL OF HEPATOLOGY

IF33

2021-01-0160

OAAI

The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2019-09-2373

OAAI

Chuan-Ming Xie

个人简介

教育背景

工作经历

荣誉奖项

研究方向